Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin

Colloids and Surfaces B: Biointerfaces

Volumn 88, Issue 1, 2011, Pages 58-62

  Li, Fang ^a   Sun, Jing ^a   Zhu, Huaishi ^b   Wen, Xuejun ^c   Lin, Chao ^c   Shi, Donglu ^c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Huangpu District Central Hospital   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Doxorubicin; Drug carrier; Magnetic; Poly(lactide co glycolide)

Indexed keywords

ANNEXINS; ANTI-TUMOR ACTIVITIES; AVERAGE SIZE; BUFFER SOLUTIONS; CANCER CHEMOTHERAPY; DOXORUBICIN; DRUG CARRIER; DRUG CONTENT; DRUG DELIVERY SYSTEM; ENCAPSULATION EFFICIENCY; IN-VITRO; MAGNETIC; MAGNETIC NANOPARTICLES; MTT ASSAYS; POLY(LACTIDE-CO-GLYCOLIDE); RESPONSIVITY; SUSTAINED RELEASE; WATER-IN-OIL-IN-WATER; WEIGHT RATIOS;

CELL DEATH; CHEMOTHERAPY; DRUG DELIVERY; DRUG PRODUCTS; EMULSIFICATION; ENCAPSULATION; NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY; VANADIUM;

NANOMAGNETICS;

DOXORUBICIN; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; MAGNETIC NANOPARTICLE; POLYGLACTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG COATING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOEMULSION; NANOENCAPSULATION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; DRUG CARRIERS; FLOW CYTOMETRY; HUMANS; LACTIC ACID; MAGNETS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; POLYGLYCOLIC ACID;

EID: 80052097542     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.06.003     Document Type: Article

References (23)

1. Florence A.T., Hillery A.M., Hussain N., Jani P.U. J. Control. Release 1995, 36:39-46.
2. Zhu L., Ma J., Jia N., Zhao Y., Shen H. Colloids Surf. B 2009, 68:1-6.
3. Xu P., Gullotti E., Tong L., Highley C.B., Errabelli D.R., Hasan T., Xin Cheng J., Kohane D.S., Yeo Y. Mol. Pharmaceut. 2008, 6:190-201.
4. Winzenburg G., Schmidt C., Fuchs S., Kissel T. Adv. Drug Deliv. Rev. 2004, 56:1453-1466.
5. Prabaharan M., Gong S. Carbohydr. Polym. 2008, 73:117-125.
6. Lina R., Nga L.S., Wang C.H. Biomaterials 2005, 26:4476-4485.
7. Jain R.A. Biomaterials 2000, 21:2475-2490.
8. Gunatillake P.A., Adhikari R. Eur. Cell Mater. 2003, 5:1-16.
9. Morelli D., Ménard S., Colnaghi M.I., Balsari A. Cancer Res. 1996, 56:2082-2085.
10. Myers C.E., Chabner B.A. Cancer Chemotherapy-Principles and Practice 1990, Lippincott, Philadelphia, pp. 356-381.
11. Hu Y., Ding Y., Ding D., Sun M., Zhang L., Jiang X., Yang C. Biomacromolecules 2007, 8:1069-1076.
12. Sunderland C.J., Steiert M., Talmadge J.E., Derfus A.M., Barry S.E. Drug Dev. Res. 2006, 67:70-93.
13. Gupta A.K., Wells S. IEEE Trans. Nanobiosci. 2004, 3:66-73.
14. Chomoucka J., Drbohlavova J., Huska D., Adam V., Kizek R., Hubalek J. Pharmacol. Res. 2010, 62:144-149.
15. Veiseh O., Gunn J.W., Zhang M. Adv. Drug Deliv. Rev. 2010, 62:284-304.
16. Yoon T.J., Kim J.S., Kim B.G., Yu K.N., Cho M.H., Lee J.K. Angew. Chem., Int. Ed. 2005, 44:1068-1071.
17. Ma J., Fan Q., Wang L., Jia N., Gu Z., Shen H. Talanta 2010, 81:1162-1169.
18. Yang J., Lee C.H., Park J., Seo S., Lim E.K., Song Y.J., Suh J.S., Yoon H.G., Huh Y.M., Haam S. J. Mater. Chem. 2007, 17:2695-2699.
19. Lu H., Yi G., Zhao S., Chen D., Guo L., Cheng J. J. Mater. Chem. 2004, 14:1336.
20. Yang Y.Y., Chung T.S., Ng N.P. Biomaterials 2001, 22:231-241.
21. Zhou S.S., Deng X., Li X. J. Control. Release 2001, 75:27-36.
22. Premanathan M., Karthikeyan K., Jeyasubramanian K., Manivannan G. Nanomedicine 2010, 10.1016/j.nano.2010.10.001.
23. Wei Z., Yuan S., Chen Y., Yu S., Hao J., Luo J., Sha X., Fang X. Eur. J. Pharm. Biopharm. 2010, 75:341-353.